Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9Y6N6
UPID:
LAMC3_HUMAN
Alternative names:
Laminin-12 subunit gamma; Laminin-14 subunit gamma; Laminin-15 subunit gamma
Alternative UPACC:
Q9Y6N6; B1APX9; B1APY0; Q59H72
Background:
Laminin subunit gamma-3, also known as Laminin-12 subunit gamma, Laminin-14 subunit gamma, and Laminin-15 subunit gamma, plays a pivotal role in the architecture of basement membranes. It is instrumental in cell attachment, migration, and tissue organization during embryonic development by interacting with other extracellular matrix components.
Therapeutic significance:
The protein's involvement in cortical malformations occipital, a condition characterized by seizures and specific brain malformations, underscores its potential as a target for therapeutic intervention. Understanding the role of Laminin subunit gamma-3 could open doors to potential therapeutic strategies.